<?xml version="1.0" encoding="utf-8"?>
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/"
   xmlns:om="http://www.ontology-of-units-of-measure.org/resource/om-2#"
   xmlns:prov="http://www.w3.org/ns/prov#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:sbol="http://sbols.org/v2#"
   xmlns:sd2="http://sd2e.org#">
  <sd2:Implementation rdf:about="http://sift.net//1.0.0">
    <sbol:persistentIdentity rdf:resource="http://sift.net/"/>
    <sbol:version>1.0.0</sbol:version>
  </sd2:Implementation>
  <prov:Activity rdf:about="http://sift.net/0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN1201/1.0.0">
    <dcterms:description>Miniprep (QIAprep Spin Miniprep Kit ) and isolate plasmids pAN3928, pAN4036, pAN1201, and pAN1717  from provided plate streaks</dcterms:description>
    <dcterms:title>Prepare Plasmids</dcterms:title>
    <sbol:displayId>0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN1201</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN1201"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#prepare_plasmids"/>
    <prov:used rdf:resource="http://sift.net//1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN1717/1.0.0">
    <dcterms:description>Miniprep (QIAprep Spin Miniprep Kit ) and isolate plasmids pAN3928, pAN4036, pAN1201, and pAN1717  from provided plate streaks</dcterms:description>
    <dcterms:title>Prepare Plasmids</dcterms:title>
    <sbol:displayId>0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN1717</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN1717"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#prepare_plasmids"/>
    <prov:used rdf:resource="http://sift.net//1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN3928/1.0.0">
    <dcterms:description>Miniprep (QIAprep Spin Miniprep Kit ) and isolate plasmids pAN3928, pAN4036, pAN1201, and pAN1717  from provided plate streaks</dcterms:description>
    <dcterms:title>Prepare Plasmids</dcterms:title>
    <sbol:displayId>0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN3928</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN3928"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#prepare_plasmids"/>
    <prov:used rdf:resource="http://sift.net//1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN4036/1.0.0">
    <dcterms:description>Miniprep (QIAprep Spin Miniprep Kit ) and isolate plasmids pAN3928, pAN4036, pAN1201, and pAN1717  from provided plate streaks</dcterms:description>
    <dcterms:title>Prepare Plasmids</dcterms:title>
    <sbol:displayId>0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN4036</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN4036"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#prepare_plasmids"/>
    <prov:used rdf:resource="http://sift.net//1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/10_rnaSeq_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01_to_10_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01_rnaSeq/1.0.0">
    <dcterms:description>8.c-dd of https://docs.google.com/document/d/1WiTOQPM9ylZqIGz86UWsODVydNsDSqJHlEZnSvkQYcs/edit?usp=sharing</dcterms:description>
    <dcterms:title>RNASeq Operator</dcterms:title>
    <sbol:displayId>10_rnaSeq_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01_to_10_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01_rnaSeq</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/10_rnaSeq_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01_to_10_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01_rnaSeq"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#rnaSeq"/>
    <prov:wasInformedBy rdf:resource="http://sift.net/9_incubate_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01/1.0.0"/>
  </prov:Activity>
  <sd2:ExperimentalData rdf:about="http://sift.net/10_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01_rnaSeq/1.0.0">
    <dcterms:title>10_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01_rnaSeq</dcterms:title>
    <sbol:displayId>10_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01_rnaSeq</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/10_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01_rnaSeq"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/10_transcriptic_rule_30_q0_1_171009_TS004_TP01_instrument_output_A1_S2_L001_R1_001_fastq_gz/1.0.0"/>
    <sd2:attachment rdf:resource="http://sift.net/10_transcriptic_rule_30_q0_1_171009_TS004_TP01_instrument_output_A1_S2_L001_R2_001_fastq_gz/1.0.0"/>
    <sd2:attachment rdf:resource="http://sift.net/10_transcriptic_rule_30_q0_1_171009_TS004_TP01_instrument_output_A1_S2_L002_R1_001_fastq_gz/1.0.0"/>
    <sd2:attachment rdf:resource="http://sift.net/10_transcriptic_rule_30_q0_1_171009_TS004_TP01_instrument_output_A1_S2_L002_R2_001_fastq_gz/1.0.0"/>
    <sd2:attachment rdf:resource="http://sift.net/10_transcriptic_rule_30_q0_1_171009_TS004_TP01_instrument_output_A1_S2_L003_R1_001_fastq_gz/1.0.0"/>
    <sd2:attachment rdf:resource="http://sift.net/10_transcriptic_rule_30_q0_1_171009_TS004_TP01_instrument_output_A1_S2_L003_R2_001_fastq_gz/1.0.0"/>
    <sd2:attachment rdf:resource="http://sift.net/10_transcriptic_rule_30_q0_1_171009_TS004_TP01_instrument_output_A1_S2_L004_R1_001_fastq_gz/1.0.0"/>
    <sd2:attachment rdf:resource="http://sift.net/10_transcriptic_rule_30_q0_1_171009_TS004_TP01_instrument_output_A1_S2_L004_R2_001_fastq_gz/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_171009_TS004_TP01_A01/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/10_rnaSeq_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01_to_10_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01_rnaSeq/1.0.0"/>
  </sd2:ExperimentalData>
  <prov:Activity rdf:about="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201/1.0.0">
    <dcterms:description>3 Transformations (one time - keeping plates for isolates)</dcterms:description>
    <dcterms:title>Transform Plasmids</dcterms:title>
    <sbol:displayId>1_transform_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transform"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717/1.0.0">
    <dcterms:description>3 Transformations (one time - keeping plates for isolates)</dcterms:description>
    <dcterms:title>Transform Plasmids</dcterms:title>
    <sbol:displayId>1_transform_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transform"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036/1.0.0">
    <dcterms:description>3 Transformations (one time - keeping plates for isolates)</dcterms:description>
    <dcterms:title>Transform Plasmids</dcterms:title>
    <sbol:displayId>1_transform_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transform"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_pAN1201_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201/1.0.0">
    <dcterms:description>3 Transformations (one time - keeping plates for isolates)</dcterms:description>
    <dcterms:title>Transform Plasmids</dcterms:title>
    <sbol:displayId>1_transform_transcriptic_rule_30_q0_1_09242017_pAN1201_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_pAN1201_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transform"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN1201/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_pAN1717_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717/1.0.0">
    <dcterms:description>3 Transformations (one time - keeping plates for isolates)</dcterms:description>
    <dcterms:title>Transform Plasmids</dcterms:title>
    <sbol:displayId>1_transform_transcriptic_rule_30_q0_1_09242017_pAN1717_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_pAN1717_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transform"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN1717/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_pAN3928_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036/1.0.0">
    <dcterms:description>3 Transformations (one time - keeping plates for isolates)</dcterms:description>
    <dcterms:title>Transform Plasmids</dcterms:title>
    <sbol:displayId>1_transform_transcriptic_rule_30_q0_1_09242017_pAN3928_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_pAN3928_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transform"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN3928/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_pAN4036_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036/1.0.0">
    <dcterms:description>3 Transformations (one time - keeping plates for isolates)</dcterms:description>
    <dcterms:title>Transform Plasmids</dcterms:title>
    <sbol:displayId>1_transform_transcriptic_rule_30_q0_1_09242017_pAN4036_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_pAN4036_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transform"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN4036/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/2_pick_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1/1.0.0">
    <dcterms:description>The day after transformation, pick single colonies and inoculate into 200 μl of M9 glucose with appropriate antibiotics in a V-bottom 96-well plate (Nunc, Roskilde, Denmark, 249952). </dcterms:description>
    <dcterms:title>Pick</dcterms:title>
    <sbol:displayId>2_pick_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/2_pick_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#pick"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/2_pick_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1/1.0.0">
    <dcterms:description>The day after transformation, pick single colonies and inoculate into 200 μl of M9 glucose with appropriate antibiotics in a V-bottom 96-well plate (Nunc, Roskilde, Denmark, 249952). </dcterms:description>
    <dcterms:title>Pick</dcterms:title>
    <sbol:displayId>2_pick_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/2_pick_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#pick"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/2_pick_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1/1.0.0">
    <dcterms:description>The day after transformation, pick single colonies and inoculate into 200 μl of M9 glucose with appropriate antibiotics in a V-bottom 96-well plate (Nunc, Roskilde, Denmark, 249952). </dcterms:description>
    <dcterms:title>Pick</dcterms:title>
    <sbol:displayId>2_pick_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/2_pick_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#pick"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A01_to_3_transcriptic_rule_30_q0_1_09242017_A01_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A01_to_3_transcriptic_rule_30_q0_1_09242017_A01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A01_to_3_transcriptic_rule_30_q0_1_09242017_A01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A01/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A02_to_3_transcriptic_rule_30_q0_1_09242017_A02_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A02_to_3_transcriptic_rule_30_q0_1_09242017_A02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A02_to_3_transcriptic_rule_30_q0_1_09242017_A02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A02/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A03_to_3_transcriptic_rule_30_q0_1_09242017_A03_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A03_to_3_transcriptic_rule_30_q0_1_09242017_A03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A03_to_3_transcriptic_rule_30_q0_1_09242017_A03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A03/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A04_to_3_transcriptic_rule_30_q0_1_09242017_A04_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A04_to_3_transcriptic_rule_30_q0_1_09242017_A04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A04_to_3_transcriptic_rule_30_q0_1_09242017_A04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A04/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A05_to_3_transcriptic_rule_30_q0_1_09242017_A05_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A05_to_3_transcriptic_rule_30_q0_1_09242017_A05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A05_to_3_transcriptic_rule_30_q0_1_09242017_A05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A05/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A06_to_3_transcriptic_rule_30_q0_1_09242017_A06_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A06_to_3_transcriptic_rule_30_q0_1_09242017_A06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A06_to_3_transcriptic_rule_30_q0_1_09242017_A06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A06/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A07_to_3_transcriptic_rule_30_q0_1_09242017_A07_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A07_to_3_transcriptic_rule_30_q0_1_09242017_A07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A07_to_3_transcriptic_rule_30_q0_1_09242017_A07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A07/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A08_to_3_transcriptic_rule_30_q0_1_09242017_A08_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A08_to_3_transcriptic_rule_30_q0_1_09242017_A08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A08_to_3_transcriptic_rule_30_q0_1_09242017_A08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A08/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A09_to_3_transcriptic_rule_30_q0_1_09242017_A09_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A09_to_3_transcriptic_rule_30_q0_1_09242017_A09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A09_to_3_transcriptic_rule_30_q0_1_09242017_A09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A09/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B01_to_3_transcriptic_rule_30_q0_1_09242017_B01_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B01_to_3_transcriptic_rule_30_q0_1_09242017_B01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B01_to_3_transcriptic_rule_30_q0_1_09242017_B01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B01/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B02_to_3_transcriptic_rule_30_q0_1_09242017_B02_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B02_to_3_transcriptic_rule_30_q0_1_09242017_B02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B02_to_3_transcriptic_rule_30_q0_1_09242017_B02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B02/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B03_to_3_transcriptic_rule_30_q0_1_09242017_B03_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B03_to_3_transcriptic_rule_30_q0_1_09242017_B03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B03_to_3_transcriptic_rule_30_q0_1_09242017_B03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B03/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B04_to_3_transcriptic_rule_30_q0_1_09242017_B04_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B04_to_3_transcriptic_rule_30_q0_1_09242017_B04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B04_to_3_transcriptic_rule_30_q0_1_09242017_B04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B04/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B05_to_3_transcriptic_rule_30_q0_1_09242017_B05_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B05_to_3_transcriptic_rule_30_q0_1_09242017_B05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B05_to_3_transcriptic_rule_30_q0_1_09242017_B05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B05/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B06_to_3_transcriptic_rule_30_q0_1_09242017_B06_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B06_to_3_transcriptic_rule_30_q0_1_09242017_B06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B06_to_3_transcriptic_rule_30_q0_1_09242017_B06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B06/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B07_to_3_transcriptic_rule_30_q0_1_09242017_B07_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B07_to_3_transcriptic_rule_30_q0_1_09242017_B07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B07_to_3_transcriptic_rule_30_q0_1_09242017_B07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B07/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B08_to_3_transcriptic_rule_30_q0_1_09242017_B08_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B08_to_3_transcriptic_rule_30_q0_1_09242017_B08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B08_to_3_transcriptic_rule_30_q0_1_09242017_B08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B08/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B09_to_3_transcriptic_rule_30_q0_1_09242017_B09_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B09_to_3_transcriptic_rule_30_q0_1_09242017_B09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B09_to_3_transcriptic_rule_30_q0_1_09242017_B09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B09/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C01_to_3_transcriptic_rule_30_q0_1_09242017_C01_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C01_to_3_transcriptic_rule_30_q0_1_09242017_C01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C01_to_3_transcriptic_rule_30_q0_1_09242017_C01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C01/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C02_to_3_transcriptic_rule_30_q0_1_09242017_C02_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C02_to_3_transcriptic_rule_30_q0_1_09242017_C02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C02_to_3_transcriptic_rule_30_q0_1_09242017_C02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C02/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C03_to_3_transcriptic_rule_30_q0_1_09242017_C03_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C03_to_3_transcriptic_rule_30_q0_1_09242017_C03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C03_to_3_transcriptic_rule_30_q0_1_09242017_C03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C03/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C04_to_3_transcriptic_rule_30_q0_1_09242017_C04_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C04_to_3_transcriptic_rule_30_q0_1_09242017_C04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C04_to_3_transcriptic_rule_30_q0_1_09242017_C04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C04/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C05_to_3_transcriptic_rule_30_q0_1_09242017_C05_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C05_to_3_transcriptic_rule_30_q0_1_09242017_C05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C05_to_3_transcriptic_rule_30_q0_1_09242017_C05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C05/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C06_to_3_transcriptic_rule_30_q0_1_09242017_C06_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C06_to_3_transcriptic_rule_30_q0_1_09242017_C06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C06_to_3_transcriptic_rule_30_q0_1_09242017_C06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C06/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C07_to_3_transcriptic_rule_30_q0_1_09242017_C07_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C07_to_3_transcriptic_rule_30_q0_1_09242017_C07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C07_to_3_transcriptic_rule_30_q0_1_09242017_C07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C07/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C08_to_3_transcriptic_rule_30_q0_1_09242017_C08_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C08_to_3_transcriptic_rule_30_q0_1_09242017_C08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C08_to_3_transcriptic_rule_30_q0_1_09242017_C08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C08/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C09_to_3_transcriptic_rule_30_q0_1_09242017_C09_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C09_to_3_transcriptic_rule_30_q0_1_09242017_C09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C09_to_3_transcriptic_rule_30_q0_1_09242017_C09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C09/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D01_to_3_transcriptic_rule_30_q0_1_09242017_D01_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D01_to_3_transcriptic_rule_30_q0_1_09242017_D01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D01_to_3_transcriptic_rule_30_q0_1_09242017_D01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D01/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D02_to_3_transcriptic_rule_30_q0_1_09242017_D02_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D02_to_3_transcriptic_rule_30_q0_1_09242017_D02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D02_to_3_transcriptic_rule_30_q0_1_09242017_D02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D02/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D03_to_3_transcriptic_rule_30_q0_1_09242017_D03_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D03_to_3_transcriptic_rule_30_q0_1_09242017_D03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D03_to_3_transcriptic_rule_30_q0_1_09242017_D03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D03/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D04_to_3_transcriptic_rule_30_q0_1_09242017_D04_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D04_to_3_transcriptic_rule_30_q0_1_09242017_D04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D04_to_3_transcriptic_rule_30_q0_1_09242017_D04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D04/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D05_to_3_transcriptic_rule_30_q0_1_09242017_D05_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D05_to_3_transcriptic_rule_30_q0_1_09242017_D05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D05_to_3_transcriptic_rule_30_q0_1_09242017_D05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D05/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D06_to_3_transcriptic_rule_30_q0_1_09242017_D06_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D06_to_3_transcriptic_rule_30_q0_1_09242017_D06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D06_to_3_transcriptic_rule_30_q0_1_09242017_D06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D06/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D07_to_3_transcriptic_rule_30_q0_1_09242017_D07_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D07_to_3_transcriptic_rule_30_q0_1_09242017_D07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D07_to_3_transcriptic_rule_30_q0_1_09242017_D07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D07/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D08_to_3_transcriptic_rule_30_q0_1_09242017_D08_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D08_to_3_transcriptic_rule_30_q0_1_09242017_D08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D08_to_3_transcriptic_rule_30_q0_1_09242017_D08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D08/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D09_to_3_transcriptic_rule_30_q0_1_09242017_D09_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D09_to_3_transcriptic_rule_30_q0_1_09242017_D09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D09_to_3_transcriptic_rule_30_q0_1_09242017_D09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D09/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E01_to_3_transcriptic_rule_30_q0_1_09242017_E01_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E01_to_3_transcriptic_rule_30_q0_1_09242017_E01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E01_to_3_transcriptic_rule_30_q0_1_09242017_E01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E01/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E02_to_3_transcriptic_rule_30_q0_1_09242017_E02_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E02_to_3_transcriptic_rule_30_q0_1_09242017_E02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E02_to_3_transcriptic_rule_30_q0_1_09242017_E02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E02/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E03_to_3_transcriptic_rule_30_q0_1_09242017_E03_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E03_to_3_transcriptic_rule_30_q0_1_09242017_E03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E03_to_3_transcriptic_rule_30_q0_1_09242017_E03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E03/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E04_to_3_transcriptic_rule_30_q0_1_09242017_E04_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E04_to_3_transcriptic_rule_30_q0_1_09242017_E04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E04_to_3_transcriptic_rule_30_q0_1_09242017_E04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E04/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E05_to_3_transcriptic_rule_30_q0_1_09242017_E05_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E05_to_3_transcriptic_rule_30_q0_1_09242017_E05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E05_to_3_transcriptic_rule_30_q0_1_09242017_E05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E05/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E06_to_3_transcriptic_rule_30_q0_1_09242017_E06_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E06_to_3_transcriptic_rule_30_q0_1_09242017_E06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E06_to_3_transcriptic_rule_30_q0_1_09242017_E06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E06/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E07_to_3_transcriptic_rule_30_q0_1_09242017_E07_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E07_to_3_transcriptic_rule_30_q0_1_09242017_E07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E07_to_3_transcriptic_rule_30_q0_1_09242017_E07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E07/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E08_to_3_transcriptic_rule_30_q0_1_09242017_E08_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E08_to_3_transcriptic_rule_30_q0_1_09242017_E08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E08_to_3_transcriptic_rule_30_q0_1_09242017_E08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E08/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E09_to_3_transcriptic_rule_30_q0_1_09242017_E09_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E09_to_3_transcriptic_rule_30_q0_1_09242017_E09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E09_to_3_transcriptic_rule_30_q0_1_09242017_E09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E09/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F01_to_3_transcriptic_rule_30_q0_1_09242017_F01_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F01_to_3_transcriptic_rule_30_q0_1_09242017_F01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F01_to_3_transcriptic_rule_30_q0_1_09242017_F01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F01/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F02_to_3_transcriptic_rule_30_q0_1_09242017_F02_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F02_to_3_transcriptic_rule_30_q0_1_09242017_F02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F02_to_3_transcriptic_rule_30_q0_1_09242017_F02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F02/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F03_to_3_transcriptic_rule_30_q0_1_09242017_F03_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F03_to_3_transcriptic_rule_30_q0_1_09242017_F03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F03_to_3_transcriptic_rule_30_q0_1_09242017_F03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F03/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F04_to_3_transcriptic_rule_30_q0_1_09242017_F04_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F04_to_3_transcriptic_rule_30_q0_1_09242017_F04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F04_to_3_transcriptic_rule_30_q0_1_09242017_F04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F04/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F05_to_3_transcriptic_rule_30_q0_1_09242017_F05_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F05_to_3_transcriptic_rule_30_q0_1_09242017_F05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F05_to_3_transcriptic_rule_30_q0_1_09242017_F05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F05/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F06_to_3_transcriptic_rule_30_q0_1_09242017_F06_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F06_to_3_transcriptic_rule_30_q0_1_09242017_F06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F06_to_3_transcriptic_rule_30_q0_1_09242017_F06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F06/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F07_to_3_transcriptic_rule_30_q0_1_09242017_F07_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F07_to_3_transcriptic_rule_30_q0_1_09242017_F07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F07_to_3_transcriptic_rule_30_q0_1_09242017_F07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F07/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F08_to_3_transcriptic_rule_30_q0_1_09242017_F08_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F08_to_3_transcriptic_rule_30_q0_1_09242017_F08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F08_to_3_transcriptic_rule_30_q0_1_09242017_F08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F08/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F09_to_3_transcriptic_rule_30_q0_1_09242017_F09_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F09_to_3_transcriptic_rule_30_q0_1_09242017_F09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F09_to_3_transcriptic_rule_30_q0_1_09242017_F09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F09/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G01_to_3_transcriptic_rule_30_q0_1_09242017_G01_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G01_to_3_transcriptic_rule_30_q0_1_09242017_G01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G01_to_3_transcriptic_rule_30_q0_1_09242017_G01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G01/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G02_to_3_transcriptic_rule_30_q0_1_09242017_G02_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G02_to_3_transcriptic_rule_30_q0_1_09242017_G02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G02_to_3_transcriptic_rule_30_q0_1_09242017_G02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G02/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G03_to_3_transcriptic_rule_30_q0_1_09242017_G03_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G03_to_3_transcriptic_rule_30_q0_1_09242017_G03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G03_to_3_transcriptic_rule_30_q0_1_09242017_G03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G03/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G04_to_3_transcriptic_rule_30_q0_1_09242017_G04_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G04_to_3_transcriptic_rule_30_q0_1_09242017_G04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G04_to_3_transcriptic_rule_30_q0_1_09242017_G04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G04/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G05_to_3_transcriptic_rule_30_q0_1_09242017_G05_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G05_to_3_transcriptic_rule_30_q0_1_09242017_G05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G05_to_3_transcriptic_rule_30_q0_1_09242017_G05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G05/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G06_to_3_transcriptic_rule_30_q0_1_09242017_G06_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G06_to_3_transcriptic_rule_30_q0_1_09242017_G06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G06_to_3_transcriptic_rule_30_q0_1_09242017_G06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G06/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G07_to_3_transcriptic_rule_30_q0_1_09242017_G07_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G07_to_3_transcriptic_rule_30_q0_1_09242017_G07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G07_to_3_transcriptic_rule_30_q0_1_09242017_G07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G07/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G08_to_3_transcriptic_rule_30_q0_1_09242017_G08_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G08_to_3_transcriptic_rule_30_q0_1_09242017_G08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G08_to_3_transcriptic_rule_30_q0_1_09242017_G08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G08/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G09_to_3_transcriptic_rule_30_q0_1_09242017_G09_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G09_to_3_transcriptic_rule_30_q0_1_09242017_G09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G09_to_3_transcriptic_rule_30_q0_1_09242017_G09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G09/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H01_to_3_transcriptic_rule_30_q0_1_09242017_H01_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H01_to_3_transcriptic_rule_30_q0_1_09242017_H01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H01_to_3_transcriptic_rule_30_q0_1_09242017_H01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H01/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H02_to_3_transcriptic_rule_30_q0_1_09242017_H02_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H02_to_3_transcriptic_rule_30_q0_1_09242017_H02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H02_to_3_transcriptic_rule_30_q0_1_09242017_H02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H02/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H03_to_3_transcriptic_rule_30_q0_1_09242017_H03_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H03_to_3_transcriptic_rule_30_q0_1_09242017_H03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H03_to_3_transcriptic_rule_30_q0_1_09242017_H03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H03/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H04_to_3_transcriptic_rule_30_q0_1_09242017_H04_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H04_to_3_transcriptic_rule_30_q0_1_09242017_H04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H04_to_3_transcriptic_rule_30_q0_1_09242017_H04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H04/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H05_to_3_transcriptic_rule_30_q0_1_09242017_H05_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H05_to_3_transcriptic_rule_30_q0_1_09242017_H05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H05_to_3_transcriptic_rule_30_q0_1_09242017_H05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H05/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H06_to_3_transcriptic_rule_30_q0_1_09242017_H06_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H06_to_3_transcriptic_rule_30_q0_1_09242017_H06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H06_to_3_transcriptic_rule_30_q0_1_09242017_H06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H06/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H07_to_3_transcriptic_rule_30_q0_1_09242017_H07_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H07_to_3_transcriptic_rule_30_q0_1_09242017_H07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H07_to_3_transcriptic_rule_30_q0_1_09242017_H07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H07/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H08_to_3_transcriptic_rule_30_q0_1_09242017_H08_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H08_to_3_transcriptic_rule_30_q0_1_09242017_H08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H08_to_3_transcriptic_rule_30_q0_1_09242017_H08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H08/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H09_to_3_transcriptic_rule_30_q0_1_09242017_H09_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H09_to_3_transcriptic_rule_30_q0_1_09242017_H09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H09_to_3_transcriptic_rule_30_q0_1_09242017_H09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H09/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_beadcontrol_to_3_transcriptic_rule_30_q0_1_09242017_beadcontrol_flowCytometry/1.0.0">
    <dcterms:title>Flow Operator</dcterms:title>
    <sbol:displayId>3_flowCytometry_transcriptic_rule_30_q0_1_09242017_beadcontrol_to_3_transcriptic_rule_30_q0_1_09242017_beadcontrol_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_beadcontrol_to_3_transcriptic_rule_30_q0_1_09242017_beadcontrol_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:instrument_configuration rdf:resource="agave://data-sd2e-community/transcriptic/instruments/cytometer_configuration.json"/>
    <sd2:manifest rdf:resource="agave://data-sd2e-community/transcriptic/rule-30_q0/1/09242017/manifest/09242017-manifest.json"/>
    <sd2:operatorType rdf:resource="http://sd2e.org#flowCytometry"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_beadcontrol/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1/1.0.0">
    <dcterms:description>Grow single colonies in sealed (Excel Scientific, Inc., AeraSeal, BS-25) V-bottom 96-well plates overnight (16 hours) at 37°C and 1000 RPM in an ELMI Digital Thermos Microplates shaker incubator (Elmi Ltd, Riga, Latvia).</dcterms:description>
    <dcterms:title>Incubate</dcterms:title>
    <sbol:displayId>3_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#incubate"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1/1.0.0">
    <dcterms:description>Grow single colonies in sealed (Excel Scientific, Inc., AeraSeal, BS-25) V-bottom 96-well plates overnight (16 hours) at 37°C and 1000 RPM in an ELMI Digital Thermos Microplates shaker incubator (Elmi Ltd, Riga, Latvia).</dcterms:description>
    <dcterms:title>Incubate</dcterms:title>
    <sbol:displayId>3_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#incubate"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/3_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1/1.0.0">
    <dcterms:description>Grow single colonies in sealed (Excel Scientific, Inc., AeraSeal, BS-25) V-bottom 96-well plates overnight (16 hours) at 37°C and 1000 RPM in an ELMI Digital Thermos Microplates shaker incubator (Elmi Ltd, Riga, Latvia).</dcterms:description>
    <dcterms:title>Incubate</dcterms:title>
    <sbol:displayId>3_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#incubate"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1/1.0.0"/>
  </prov:Activity>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A01_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_A01_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_A01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_A1_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A01/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A01_to_3_transcriptic_rule_30_q0_1_09242017_A01_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A02_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_A02_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_A02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_A2_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A02/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A02_to_3_transcriptic_rule_30_q0_1_09242017_A02_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A03_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_A03_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_A03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_A3_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A03/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A03_to_3_transcriptic_rule_30_q0_1_09242017_A03_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A04_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_A04_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_A04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_A4_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A04/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A04_to_3_transcriptic_rule_30_q0_1_09242017_A04_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A05_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_A05_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_A05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_A5_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A05/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A05_to_3_transcriptic_rule_30_q0_1_09242017_A05_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A06_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_A06_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_A06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_A6_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A06/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A06_to_3_transcriptic_rule_30_q0_1_09242017_A06_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A07_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_A07_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_A07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_A7_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A07/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A07_to_3_transcriptic_rule_30_q0_1_09242017_A07_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A08_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_A08_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_A08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_A8_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A08/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A08_to_3_transcriptic_rule_30_q0_1_09242017_A08_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A09_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_A09_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_A09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_A9_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A09/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_A09_to_3_transcriptic_rule_30_q0_1_09242017_A09_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B01_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_B01_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_B01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_B1_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B01/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B01_to_3_transcriptic_rule_30_q0_1_09242017_B01_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B02_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_B02_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_B02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_B2_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B02/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B02_to_3_transcriptic_rule_30_q0_1_09242017_B02_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B03_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_B03_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_B03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_B3_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B03/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B03_to_3_transcriptic_rule_30_q0_1_09242017_B03_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B04_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_B04_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_B04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_B4_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B04/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B04_to_3_transcriptic_rule_30_q0_1_09242017_B04_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B05_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_B05_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_B05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_B5_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B05/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B05_to_3_transcriptic_rule_30_q0_1_09242017_B05_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B06_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_B06_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_B06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_B6_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B06/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B06_to_3_transcriptic_rule_30_q0_1_09242017_B06_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B07_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_B07_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_B07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_B7_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B07/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B07_to_3_transcriptic_rule_30_q0_1_09242017_B07_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B08_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_B08_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_B08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_B8_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B08/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B08_to_3_transcriptic_rule_30_q0_1_09242017_B08_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B09_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_B09_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_B09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_B9_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B09/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_B09_to_3_transcriptic_rule_30_q0_1_09242017_B09_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C01_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_C01_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_C01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_C1_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C01/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C01_to_3_transcriptic_rule_30_q0_1_09242017_C01_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C02_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_C02_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_C02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_C2_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C02/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C02_to_3_transcriptic_rule_30_q0_1_09242017_C02_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C03_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_C03_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_C03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_C3_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C03/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C03_to_3_transcriptic_rule_30_q0_1_09242017_C03_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C04_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_C04_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_C04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_C4_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C04/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C04_to_3_transcriptic_rule_30_q0_1_09242017_C04_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C05_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_C05_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_C05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_C5_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C05/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C05_to_3_transcriptic_rule_30_q0_1_09242017_C05_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C06_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_C06_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_C06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_C6_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C06/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C06_to_3_transcriptic_rule_30_q0_1_09242017_C06_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C07_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_C07_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_C07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_C7_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C07/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C07_to_3_transcriptic_rule_30_q0_1_09242017_C07_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C08_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_C08_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_C08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_C8_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C08/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C08_to_3_transcriptic_rule_30_q0_1_09242017_C08_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C09_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_C09_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_C09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_C9_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C09/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_C09_to_3_transcriptic_rule_30_q0_1_09242017_C09_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D01_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_D01_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_D01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_D1_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D01/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D01_to_3_transcriptic_rule_30_q0_1_09242017_D01_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D02_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_D02_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_D02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_D2_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D02/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D02_to_3_transcriptic_rule_30_q0_1_09242017_D02_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D03_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_D03_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_D03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_D3_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D03/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D03_to_3_transcriptic_rule_30_q0_1_09242017_D03_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D04_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_D04_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_D04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_D4_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D04/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D04_to_3_transcriptic_rule_30_q0_1_09242017_D04_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D05_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_D05_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_D05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_D5_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D05/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D05_to_3_transcriptic_rule_30_q0_1_09242017_D05_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D06_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_D06_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_D06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_D6_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D06/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D06_to_3_transcriptic_rule_30_q0_1_09242017_D06_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D07_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_D07_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_D07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_D7_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D07/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D07_to_3_transcriptic_rule_30_q0_1_09242017_D07_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D08_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_D08_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_D08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_D8_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D08/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D08_to_3_transcriptic_rule_30_q0_1_09242017_D08_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D09_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_D09_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_D09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_D9_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D09/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_D09_to_3_transcriptic_rule_30_q0_1_09242017_D09_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E01_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_E01_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_E01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_E1_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E01/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E01_to_3_transcriptic_rule_30_q0_1_09242017_E01_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E02_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_E02_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_E02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_E2_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E02/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E02_to_3_transcriptic_rule_30_q0_1_09242017_E02_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E03_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_E03_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_E03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_E3_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E03/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E03_to_3_transcriptic_rule_30_q0_1_09242017_E03_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E04_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_E04_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_E04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_E4_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E04/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E04_to_3_transcriptic_rule_30_q0_1_09242017_E04_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E05_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_E05_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_E05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_E5_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E05/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E05_to_3_transcriptic_rule_30_q0_1_09242017_E05_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E06_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_E06_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_E06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_E6_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E06/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E06_to_3_transcriptic_rule_30_q0_1_09242017_E06_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E07_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_E07_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_E07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_E7_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E07/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E07_to_3_transcriptic_rule_30_q0_1_09242017_E07_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E08_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_E08_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_E08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_E8_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E08/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E08_to_3_transcriptic_rule_30_q0_1_09242017_E08_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E09_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_E09_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_E09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_E9_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E09/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_E09_to_3_transcriptic_rule_30_q0_1_09242017_E09_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F01_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_F01_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_F01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_F1_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F01/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F01_to_3_transcriptic_rule_30_q0_1_09242017_F01_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F02_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_F02_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_F02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_F2_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F02/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F02_to_3_transcriptic_rule_30_q0_1_09242017_F02_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F03_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_F03_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_F03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_F3_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F03/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F03_to_3_transcriptic_rule_30_q0_1_09242017_F03_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F04_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_F04_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_F04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_F4_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F04/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F04_to_3_transcriptic_rule_30_q0_1_09242017_F04_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F05_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_F05_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_F05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_F5_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F05/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F05_to_3_transcriptic_rule_30_q0_1_09242017_F05_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F06_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_F06_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_F06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_F6_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F06/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F06_to_3_transcriptic_rule_30_q0_1_09242017_F06_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F07_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_F07_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_F07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_F7_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F07/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F07_to_3_transcriptic_rule_30_q0_1_09242017_F07_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F08_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_F08_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_F08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_F8_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F08/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F08_to_3_transcriptic_rule_30_q0_1_09242017_F08_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F09_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_F09_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_F09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_F9_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F09/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_F09_to_3_transcriptic_rule_30_q0_1_09242017_F09_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G01_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_G01_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_G01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_G1_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G01/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G01_to_3_transcriptic_rule_30_q0_1_09242017_G01_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G02_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_G02_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_G02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_G2_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G02/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G02_to_3_transcriptic_rule_30_q0_1_09242017_G02_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G03_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_G03_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_G03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_G3_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G03/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G03_to_3_transcriptic_rule_30_q0_1_09242017_G03_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G04_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_G04_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_G04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_G4_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G04/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G04_to_3_transcriptic_rule_30_q0_1_09242017_G04_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G05_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_G05_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_G05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_G5_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G05/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G05_to_3_transcriptic_rule_30_q0_1_09242017_G05_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G06_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_G06_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_G06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_G6_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G06/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G06_to_3_transcriptic_rule_30_q0_1_09242017_G06_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G07_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_G07_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_G07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_G7_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G07/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G07_to_3_transcriptic_rule_30_q0_1_09242017_G07_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G08_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_G08_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_G08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_G8_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G08/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G08_to_3_transcriptic_rule_30_q0_1_09242017_G08_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G09_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_G09_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_G09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_G9_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G09/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_G09_to_3_transcriptic_rule_30_q0_1_09242017_G09_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H01_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_H01_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_H01_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H01_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_H1_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H01/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H01_to_3_transcriptic_rule_30_q0_1_09242017_H01_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H02_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_H02_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_H02_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H02_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_H2_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H02/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H02_to_3_transcriptic_rule_30_q0_1_09242017_H02_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H03_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_H03_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_H03_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H03_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_H3_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H03/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H03_to_3_transcriptic_rule_30_q0_1_09242017_H03_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H04_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_H04_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_H04_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H04_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_H4_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H04/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H04_to_3_transcriptic_rule_30_q0_1_09242017_H04_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H05_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_H05_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_H05_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H05_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_H5_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H05/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H05_to_3_transcriptic_rule_30_q0_1_09242017_H05_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H06_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_H06_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_H06_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H06_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_H6_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H06/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H06_to_3_transcriptic_rule_30_q0_1_09242017_H06_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H07_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_H07_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_H07_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H07_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_H7_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H07/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H07_to_3_transcriptic_rule_30_q0_1_09242017_H07_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H08_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_H08_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_H08_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H08_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_H8_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H08/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H08_to_3_transcriptic_rule_30_q0_1_09242017_H08_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H09_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_H09_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_H09_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H09_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_H9_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H09/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_H09_to_3_transcriptic_rule_30_q0_1_09242017_H09_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <sd2:ExperimentalData rdf:about="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_beadcontrol_flowCytometry/1.0.0">
    <dcterms:title>3_transcriptic_rule_30_q0_1_09242017_beadcontrol_flowCytometry</dcterms:title>
    <sbol:displayId>3_transcriptic_rule_30_q0_1_09242017_beadcontrol_flowCytometry</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_beadcontrol_flowCytometry"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:attachment rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_instrument_output_SD30_09242017_SD30_09242017_Rule30Plate_A12_fcs/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_beadcontrol/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/3_flowCytometry_transcriptic_rule_30_q0_1_09242017_beadcontrol_to_3_transcriptic_rule_30_q0_1_09242017_beadcontrol_flowCytometry/1.0.0"/>
  </sd2:ExperimentalData>
  <prov:Activity rdf:about="http://sift.net/4_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2/1.0.0">
    <dcterms:description>The next day, dilute the overnight cultures 178-fold by adding 15 μL of culture into 185  μL M9 glucose media, and then 15 μL of that dilution into 185 μL 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate.</dcterms:description>
    <dcterms:title>Dilute</dcterms:title>
    <sbol:displayId>4_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/4_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#dilute"/>
    <prov:wasInformedBy rdf:resource="http://sift.net/3_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/4_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2/1.0.0">
    <dcterms:description>The next day, dilute the overnight cultures 178-fold by adding 15 μL of culture into 185  μL M9 glucose media, and then 15 μL of that dilution into 185 μL 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate.</dcterms:description>
    <dcterms:title>Dilute</dcterms:title>
    <sbol:displayId>4_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/4_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#dilute"/>
    <prov:wasInformedBy rdf:resource="http://sift.net/3_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/4_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2/1.0.0">
    <dcterms:description>The next day, dilute the overnight cultures 178-fold by adding 15 μL of culture into 185  μL M9 glucose media, and then 15 μL of that dilution into 185 μL 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate.</dcterms:description>
    <dcterms:title>Dilute</dcterms:title>
    <sbol:displayId>4_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/4_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#dilute"/>
    <prov:wasInformedBy rdf:resource="http://sift.net/3_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/5_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2/1.0.0">
    <dcterms:description>Grow the diluted cultures in an ELMI shaker incubator at 37 °C and 1000 RPM for three hours.</dcterms:description>
    <dcterms:title>Incubate</dcterms:title>
    <sbol:displayId>5_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/5_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#incubate"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/5_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2/1.0.0">
    <dcterms:description>Grow the diluted cultures in an ELMI shaker incubator at 37 °C and 1000 RPM for three hours.</dcterms:description>
    <dcterms:title>Incubate</dcterms:title>
    <sbol:displayId>5_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/5_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#incubate"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/5_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2/1.0.0">
    <dcterms:description>Grow the diluted cultures in an ELMI shaker incubator at 37 °C and 1000 RPM for three hours.</dcterms:description>
    <dcterms:title>Incubate</dcterms:title>
    <sbol:displayId>5_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/5_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#incubate"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/6_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Dilute the cultures from Step 6 by adding 15 μL of culture into 185 μL of M9 glucose media.</dcterms:description>
    <dcterms:title>Dilute</dcterms:title>
    <sbol:displayId>6_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/6_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#dilute"/>
    <prov:wasInformedBy rdf:resource="http://sift.net/5_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/6_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Dilute the cultures from Step 6 by adding 15 μL of culture into 185 μL of M9 glucose media.</dcterms:description>
    <dcterms:title>Dilute</dcterms:title>
    <sbol:displayId>6_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/6_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#dilute"/>
    <prov:wasInformedBy rdf:resource="http://sift.net/5_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/6_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Dilute the cultures from Step 6 by adding 15 μL of culture into 185 μL of M9 glucose media.</dcterms:description>
    <dcterms:title>Dilute</dcterms:title>
    <sbol:displayId>6_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/6_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#dilute"/>
    <prov:wasInformedBy rdf:resource="http://sift.net/5_incubate_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_A01/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_A01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_A01"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_A02/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_A02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_A02"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_A03/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_A03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_A03"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_B01/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_B01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_B01"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_B02/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_B02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_B02"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_B03/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_B03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_B03"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_C01/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_C01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_C01"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_C02/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_C02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_C02"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_C03/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_C03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_C03"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_D01/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_D01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_D01"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_D02/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_D02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_D02"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_D03/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_D03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_D03"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_E01/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_E01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_E01"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_E02/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_E02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_E02"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_E03/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_E03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_E03"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_F01/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_F01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_F01"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_F02/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_F02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_F02"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_F03/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_F03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_F03"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_G01/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_G01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_G01"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_G02/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_G02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_G02"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_G03/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_G03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_G03"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_H01/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_H01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_H01"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_H02/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_H02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_H02"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_H03/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_H03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_H03"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_A07/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_A07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_A07"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_A08/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_A08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_A08"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_A09/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_A09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_A09"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_B07/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_B07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_B07"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_B08/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_B08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_B08"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_B09/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_B09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_B09"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_C07/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_C07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_C07"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_C08/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_C08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_C08"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_C09/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_C09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_C09"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_D07/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_D07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_D07"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_D08/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_D08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_D08"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_D09/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_D09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_D09"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_E07/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_E07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_E07"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_E08/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_E08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_E08"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_E09/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_E09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_E09"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_F07/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_F07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_F07"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_F08/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_F08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_F08"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_F09/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_F09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_F09"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_G07/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_G07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_G07"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_G08/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_G08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_G08"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_G09/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_G09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_G09"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_H07/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_H07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_H07"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_H08/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_H08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_H08"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_H09/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_H09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_H09"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_A04/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_A04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_A04"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_A05/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_A05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_A05"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_A06/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_A06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_A06"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_B04/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_B04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_B04"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_B05/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_B05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_B05"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_B06/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_B06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_B06"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_C04/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_C04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_C04"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_C05/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_C05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_C05"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_C06/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_C06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_C06"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_D04/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_D04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_D04"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_D05/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_D05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_D05"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_D06/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_D06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_D06"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_E04/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_E04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_E04"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_E05/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_E05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_E05"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_E06/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_E06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_E06"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_F04/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_F04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_F04"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_F05/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_F05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_F05"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_F06/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_F06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_F06"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_G04/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_G04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_G04"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_G05/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_G05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_G05"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_G06/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_G06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_G06"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_H04/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_H04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_H04"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_H05/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_H05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_H05"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_H06/1.0.0">
    <dcterms:description>Branch 1 -&gt; Flow cytometry: Take 3 μL of that dilution and distribute into eight wells with 145 μL inducer-containing M9 glucose media with 50 μg/mL kanamycin and 50 μg/mL spectinomycin in a V-bottom 96-well plate. The eight wells correspond to the inducer conditions (—/—/—), (—/—/+), (—/+/—), (— /+/+), (+/—/—), (+/—/+), (+/+/—), and (+/+/+). Each — or + corresponds to the absence or presence of 5 mM L-arabinose (Sigma-Aldrich, MO, A3256), 2 ng/mL aTc (anhydrotetracycline hydrochloride; Sigma-Aldrich, MO, 37919), and 1 mM IPTG (isopropyl β-D-1- thiogalactopyranoside; Sigma-Aldrich, MO, I6758).</dcterms:description>
    <dcterms:title>Transfer</dcterms:title>
    <sbol:displayId>7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_H06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_H06"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#transfer"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/8_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01/1.0.0">
    <dcterms:description>Dilute the cultures from Step 6 by transferring 4.56 μL of culture into 8 Falcon tubes (14 mL round-bottom polypropylene tubes; Corning, MA, 352059) each containing 3 mL of M9 glucose media with appropriate inducers and with 50 μg/mL kanamycin and 50 μg/mL spectinomycin. The inducer conditions have been described above in section 7c. </dcterms:description>
    <dcterms:title>Dilute</dcterms:title>
    <sbol:displayId>8_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/8_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#dilute"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </prov:Activity>
  <prov:Activity rdf:about="http://sift.net/9_incubate_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01/1.0.0">
    <dcterms:description>Grow the cultures containing inducer in an Innova 44 shaker (Eppendorf, CT) at 370C and 250 RPM for five hours.</dcterms:description>
    <dcterms:title>Incubate</dcterms:title>
    <sbol:displayId>9_incubate_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/9_incubate_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:operatorType rdf:resource="http://sd2e.org#incubate"/>
    <prov:used rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_171009_TS004_TP01_A01/1.0.0"/>
  </prov:Activity>
  <sd2:Experiment rdf:about="http://sift.net/b7cf7a75_9769_4d54_a807_ac81b92fb0af/1.0.0">
    <dcterms:title>Rule30 Q0 Plan</dcterms:title>
    <sbol:displayId>b7cf7a75_9769_4d54_a807_ac81b92fb0af</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/b7cf7a75_9769_4d54_a807_ac81b92fb0af"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:experimentalData rdf:resource="http://sift.net/10_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01_rnaSeq/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A01_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A02_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A03_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A04_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A05_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A06_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A07_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A08_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_A09_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B01_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B02_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B03_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B04_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B05_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B06_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B07_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B08_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_B09_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C01_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C02_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C03_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C04_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C05_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C06_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C07_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C08_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_C09_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D01_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D02_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D03_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D04_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D05_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D06_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D07_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D08_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_D09_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E01_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E02_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E03_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E04_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E05_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E06_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E07_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E08_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_E09_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F01_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F02_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F03_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F04_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F05_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F06_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F07_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F08_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_F09_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G01_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G02_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G03_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G04_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G05_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G06_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G07_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G08_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_G09_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H01_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H02_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H03_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H04_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H05_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H06_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H07_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H08_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_H09_flowCytometry/1.0.0"/>
    <sd2:experimentalData rdf:resource="http://sift.net/3_transcriptic_rule_30_q0_1_09242017_beadcontrol_flowCytometry/1.0.0"/>
  </sd2:Experiment>
  <om:Unit rdf:about="http://sift.net/microlitre/1.0.0">
    <dcterms:title>microliter</dcterms:title>
    <sbol:displayId>microlitre</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/microlitre"/>
    <sbol:version>1.0.0</sbol:version>
    <om:symbol>μl</om:symbol>
    <prov:wasDerivedFrom rdf:resource="http://www.ontology-of-units-of-measure.org/resource/om-2/microlitre"/>
  </om:Unit>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_A01/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_A01</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_A01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A01"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_A01/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_A02/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_A02</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_A02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A02"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_A02/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_A03/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_A03</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_A03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A03"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_A03/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_A04/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_A04</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_A04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A04"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_A04/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_A05/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_A05</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_A05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A05"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_A05/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_A06/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_A06</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_A06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A06"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_A06/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_A07/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_A07</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_A07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A07"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_A07/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_A08/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_A08</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_A08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A08"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_A08/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_A09/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_A09</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_A09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_A09"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_A09/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_B01/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_B01</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_B01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B01"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_B01/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_B02/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_B02</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_B02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B02"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_B02/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_B03/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_B03</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_B03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B03"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_B03/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_B04/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_B04</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_B04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B04"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_B04/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_B05/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_B05</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_B05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B05"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_B05/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_B06/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_B06</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_B06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B06"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_B06/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_B07/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_B07</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_B07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B07"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_B07/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_B08/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_B08</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_B08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B08"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_B08/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_B09/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_B09</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_B09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_B09"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_B09/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_C01/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_C01</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_C01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C01"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_C01/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_C02/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_C02</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_C02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C02"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_C02/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_C03/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_C03</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_C03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C03"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_C03/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_C04/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_C04</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_C04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C04"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_C04/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_C05/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_C05</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_C05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C05"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_C05/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_C06/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_C06</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_C06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C06"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_C06/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_C07/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_C07</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_C07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C07"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_C07/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_C08/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_C08</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_C08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C08"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_C08/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_C09/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_C09</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_C09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_C09"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_C09/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_D01/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_D01</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_D01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D01"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_D01/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_D02/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_D02</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_D02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D02"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_D02/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_D03/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_D03</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_D03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D03"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_D03/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_D04/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_D04</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_D04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D04"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_D04/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_D05/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_D05</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_D05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D05"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_D05/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_D06/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_D06</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_D06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D06"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_D06/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_D07/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_D07</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_D07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D07"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_D07/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_D08/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_D08</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_D08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D08"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_D08/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_D09/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_D09</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_D09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_D09"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_D09/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_E01/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_E01</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_E01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E01"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_E01/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_E02/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_E02</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_E02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E02"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_E02/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_E03/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_E03</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_E03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E03"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_E03/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_E04/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_E04</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_E04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E04"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_E04/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_E05/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_E05</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_E05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E05"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_E05/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_E06/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_E06</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_E06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E06"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_E06/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_E07/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_E07</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_E07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E07"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_E07/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_E08/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_E08</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_E08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E08"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_E08/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_E09/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_E09</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_E09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_E09"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_E09/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_F01/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_F01</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_F01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F01"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_F01/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_F02/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_F02</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_F02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F02"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_F02/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_F03/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_F03</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_F03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F03"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_F03/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_F04/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_F04</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_F04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F04"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_F04/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_F05/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_F05</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_F05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F05"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_F05/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_F06/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_F06</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_F06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F06"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_F06/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_F07/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_F07</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_F07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F07"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_F07/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_F08/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_F08</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_F08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F08"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_F08/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_F09/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_F09</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_F09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_F09"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_F09/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_G01/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_G01</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_G01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G01"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_G01/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_G02/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_G02</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_G02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G02"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_G02/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_G03/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_G03</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_G03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G03"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_G03/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_G04/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_G04</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_G04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G04"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_G04/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_G05/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_G05</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_G05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G05"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_G05/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_G06/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_G06</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_G06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G06"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_G06/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_G07/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_G07</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_G07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G07"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_G07/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_G08/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_G08</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_G08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G08"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_G08/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_G09/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_G09</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_G09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_G09"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_G09/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_H01/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_H01</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_H01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H01"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_H01/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_H02/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_H02</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_H02</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H02"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_H02/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_H03/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_H03</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_H03</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H03"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_09242017_H03/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_H04/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_H04</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_H04</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H04"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_H04/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_H05/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_H05</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_H05</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H05"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_H05/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_H06/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_H06</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_H06</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H06"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3_to_transcriptic_rule_30_q0_1_09242017_H06/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_H07/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_H07</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_H07</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H07"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_H07/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_H08/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_H08</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_H08</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H08"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_H08/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_H09/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_H09</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_H09</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_H09"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/7_transfer_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3_to_transcriptic_rule_30_q0_1_09242017_H09/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_NEB_10_beta</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_NEB_10_beta</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta"/>
    <sbol:version>1.0.0</sbol:version>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN1201/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_pAN1201_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/2_pick_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:measure>
      <om:Measure rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2/volume/1.0.0">
        <dcterms:title>volume</dcterms:title>
        <sbol:displayId>volume</sbol:displayId>
        <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2/volume"/>
        <sbol:version>1.0.0</sbol:version>
        <om:hasNumericalValue>15</om:hasNumericalValue>
        <om:hasUnit rdf:resource="http://sift.net/microlitre/1.0.0"/>
      </om:Measure>
    </sd2:measure>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/4_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_1_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:measure>
      <om:Measure rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/volume/1.0.0">
        <dcterms:title>volume</dcterms:title>
        <sbol:displayId>volume</sbol:displayId>
        <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/volume"/>
        <sbol:version>1.0.0</sbol:version>
        <om:hasNumericalValue>15</om:hasNumericalValue>
        <om:hasUnit rdf:resource="http://sift.net/microlitre/1.0.0"/>
      </om:Measure>
    </sd2:measure>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/6_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_2_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN1717/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_pAN1717_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/2_pick_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:measure>
      <om:Measure rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2/volume/1.0.0">
        <dcterms:title>volume</dcterms:title>
        <sbol:displayId>volume</sbol:displayId>
        <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2/volume"/>
        <sbol:version>1.0.0</sbol:version>
        <om:hasNumericalValue>15</om:hasNumericalValue>
        <om:hasUnit rdf:resource="http://sift.net/microlitre/1.0.0"/>
      </om:Measure>
    </sd2:measure>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/4_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_1_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:measure>
      <om:Measure rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/volume/1.0.0">
        <dcterms:title>volume</dcterms:title>
        <sbol:displayId>volume</sbol:displayId>
        <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/volume"/>
        <sbol:version>1.0.0</sbol:version>
        <om:hasNumericalValue>15</om:hasNumericalValue>
        <om:hasUnit rdf:resource="http://sift.net/microlitre/1.0.0"/>
      </om:Measure>
    </sd2:measure>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/6_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_2_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1717_3/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN3928/1.0.0"/>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN4036/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_pAN3928_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/1_transform_transcriptic_rule_30_q0_1_09242017_pAN4036_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/2_pick_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:measure>
      <om:Measure rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2/volume/1.0.0">
        <dcterms:title>volume</dcterms:title>
        <sbol:displayId>volume</sbol:displayId>
        <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2/volume"/>
        <sbol:version>1.0.0</sbol:version>
        <om:hasNumericalValue>15</om:hasNumericalValue>
        <om:hasUnit rdf:resource="http://sift.net/microlitre/1.0.0"/>
      </om:Measure>
    </sd2:measure>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/4_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_1_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:measure>
      <om:Measure rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/volume/1.0.0">
        <dcterms:title>volume</dcterms:title>
        <sbol:displayId>volume</sbol:displayId>
        <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/volume"/>
        <sbol:version>1.0.0</sbol:version>
        <om:hasNumericalValue>15</om:hasNumericalValue>
        <om:hasUnit rdf:resource="http://sift.net/microlitre/1.0.0"/>
      </om:Measure>
    </sd2:measure>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/6_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_2_to_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN3928_pAN4036_3/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_beadcontrol/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_beadcontrol</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_beadcontrol</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_beadcontrol"/>
    <sbol:version>1.0.0</sbol:version>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN1201/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_pAN1201</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_pAN1201</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN1201"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net//1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN1201/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN1717/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_pAN1717</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_pAN1717</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN1717"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net//1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN1717/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN3928/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_pAN3928</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_pAN3928</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN3928"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net//1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN3928/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN4036/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_09242017_pAN4036</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_09242017_pAN4036</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_pAN4036"/>
    <sbol:version>1.0.0</sbol:version>
    <prov:wasDerivedFrom rdf:resource="http://sift.net//1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/0_prepare_plasmids__to_transcriptic_rule_30_q0_1_09242017_pAN4036/1.0.0"/>
  </sd2:Implementation>
  <sd2:Implementation rdf:about="http://sift.net/transcriptic_rule_30_q0_1_171009_TS004_TP01_A01/1.0.0">
    <dcterms:title>transcriptic_rule_30_q0_1_171009_TS004_TP01_A01</dcterms:title>
    <sbol:displayId>transcriptic_rule_30_q0_1_171009_TS004_TP01_A01</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_171009_TS004_TP01_A01"/>
    <sbol:version>1.0.0</sbol:version>
    <sd2:measure>
      <om:Measure rdf:about="http://sift.net/transcriptic_rule_30_q0_1_171009_TS004_TP01_A01/volume/1.0.0">
        <dcterms:title>volume</dcterms:title>
        <sbol:displayId>volume</sbol:displayId>
        <sbol:persistentIdentity rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_171009_TS004_TP01_A01/volume"/>
        <sbol:version>1.0.0</sbol:version>
        <om:hasNumericalValue>4.56</om:hasNumericalValue>
        <om:hasUnit rdf:resource="http://sift.net/microlitre/1.0.0"/>
      </om:Measure>
    </sd2:measure>
    <prov:wasDerivedFrom rdf:resource="http://sift.net/transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3/1.0.0"/>
    <prov:wasGeneratedBy rdf:resource="http://sift.net/8_dilute_transcriptic_rule_30_q0_1_09242017_NEB_10_beta_pAN1201_3_to_transcriptic_rule_30_q0_1_171009_TS004_TP01_A01/1.0.0"/>
  </sd2:Implementation>
</rdf:RDF>
